Two faces of MAC-induced lung disease.
Lung disease due to mycobacterium avium complex (MAC) is being increasingly recognized. The clinical and radiological manifestations are varied and treatment is complex. We present two cases of MAC-induced lung disease to illustrate this disease.
Tetenta
Sodienye
S
Pulmonary/Critical Care Medicine, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT 06032, USA.
Abunasser
Jafar
J
Bandyopadhyay
Tapas
T
D000368:Aged; D017963:Azithromycin / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D015269:Mycobacterium avium Complex / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D012293:Rifampin / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D017963:Azithromycin; D004977:Ethambutol; D012293:Rifampin